checkAd

     113  0 Kommentare Genenta Science and AGC Biologics Enter Development and Manufacturing Service Agreement - Seite 3

    Investor Relations - LifeSci Advisors  Genenta Media
    Mary-Ann Chang, CFA Tiziana Pollio
    +44 7483 28 48 53 +39 348 23 15 143
    mchang@lifesciadvisors.com tiziana.pollio@genenta.com
       
    AGC Biologics  
    Nick McDonald  
    +1 (425) 419-3555  
    nmcdonald@agcbio.com  


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Genenta Science and AGC Biologics Enter Development and Manufacturing Service Agreement - Seite 3 MILAN, N.Y., Feb. 07, 2023 (GLOBE NEWSWIRE) - Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company engaged in the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, has entered into a development …